title: CELF-mediated alternative splicing is required for cardiac function during early, but not later, postnatal life.
abstract: During the transition from juvenile to adult life, the heart undergoes programmed remodeling at the levels of transcription and alternative splicing. Members of the CUG-BP and ETR-3-like factor (CELF) family have been implicated in driving developmental transitions in alternative splicing of cardiac transcripts during maturation of the heart. Here, we investigated the timing of the requirement for CELF activity in the postnatal heart using a previously described transgenic mouse model (MHC-CELFDelta). In MHC-CELFDelta mice, nuclear CELF activity has been disrupted specifically in the heart by cardiac-specific expression of a dominant negative CELF protein. Longitudinal analyses of two lines of MHC-CELFDelta mice with differing levels of dominant negative protein expression demonstrate that CELF splicing activity is required for healthy cardiac function during juvenile, but not adult, life. Cardiac function, chamber dilation, and heart size all recover with age in the mild line of MHC-CELFDelta mice without a loss of dominant negative protein expression or change in expression of endogenous CELF proteins or known CELF antagonists. This is the first example of a mouse model with genetically induced cardiomyopathy that spontaneously recovers without intervention. Our results suggest that CELF proteins are key players in the integrated gene expression program involved in postnatal cardiac remodeling and maturation.
authors.affiliation: Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave. NC10, Cleveland, OH 44195, USA.
authors.forename: Fulvia
authors.initials: F
authors.lastname: Terenzi
authors.forename: Kyle R
authors.initials: KR
authors.lastname: Brimacombe
authors.forename: Marc S
authors.initials: MS
authors.lastname: Penn
authors.forename: Andrea N
authors.initials: AN
authors.lastname: Ladd
mesh_terms: D000375:Aging / Q000235:genetics / Q000378:metabolism*; D017398:Alternative Splicing / Q000502:physiology*; D000818:Animals; D051743:CCAAT-Enhancer-Binding Protein-delta / Q000096:biosynthesis* / Q000235:genetics; D009202:Cardiomyopathies / Q000235:genetics / Q000378:metabolism; D005260:Female; D006321:Heart / Q000254:growth & development*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009124:Muscle Proteins / Q000096:biosynthesis* / Q000235:genetics; D009206:Myocardium / Q000378:metabolism*; D009929:Organ Size / Q000502:physiology; D009928:Organ Specificity / Q000502:physiology
chemical_list: C497253:Cebpd protein, mouse; D009124:Muscle Proteins; D051743:CCAAT-Enhancer-Binding Protein-delta